Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02592551
Title MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

malignant pleural mesothelioma

Therapies

Durvalumab + Tremelimumab

Durvalumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.